BMS 为何在筛选 CMO 合作伙伴时考察数字化能力

BMS’s Kevin Cook explains why digital capability is becoming a must-have for strategic CMO partners and why the next phase starts with the basics.

Bristol Myers Squibb (BMS) is raising the bar on digital capability for its strategic contract manufacturing partners, according to Kevin Cook, vice president, global pharm and biologics supply chain, BMS.

Speaking with Pharmaceutical Commerce at LogiPharma USA 2026, Cook says BMS is actively screening for digital capabilities among its contract manufacturing organization (CMO) partners. In the past, he says, those capabilities were “a nice-to-have,” but “now it’s becoming a must-have.”

Cook says BMS looks at whether its suppliers and CMOs have a digital strategy, can connect with BMS digitally and have a digital way of working, which also lays the groundwork for agentic and AI capabilities in the future.

Looking ahead, Cook says the next phase of CMO partnerships starts with getting the basics right. “Even basic exchanges of transactional data, inventories, orders, schedules, is something that we have to get better at,” he says.

Once the relationship and transactional processes are up and running, Cook says partners can expand into sharing capacities and forecasts that extend from the short term into the mid and long term. From there, he sees BMS and its CMOs becoming true partners that integrate their business plans, whether for inline supply or for launching new products and jointly developing new technologies for patients.

Survey data show how much ground remains on those basics. In WBR Insights’ LogiPharma Playbook 2026, a combined 68% of supply chain leaders surveyed said collaboration with CMOs at the manufacturing and quality level is still manual, while 32% described it as largely digitalized with structured data sharing.¹ A MasterControl survey of more than 50 global CDMOs found that 92% report sponsors raising digital requirements in contract negotiations.²

Watch Cook’s previous interview clip:

1. BMS’s Kevin Cook on Moving CMO Partnerships Beyond Transactions.

References

1. LogiPharma Playbook: 2026 Supply Chain & Logistics Insights. WBR Insights. March 2026. Accessed October 27, 2026. https://eco-cdn.iqpc.com/eco/files/event_content/4223-logipharma-2026-playbook-report-28pp-webv2OWx8dcAS3F9xcbL5dqFED6J24ZcitqX6piZvsm.pdf

2. The Digital Divide in Contract Manufacturing: Why 92% of CDMOs Are Facing a Defining Moment. MasterControl. January 15, 2026. Accessed October 27, 2026. https://www.mastercontrol.com/gxp-lifeline/pharmasource-surveys-cdmo-digital-manufacturing/

Related to this article